Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Identification and characterization of quiescent brain tumor stem cells

EF 2010-11

Résumé
In Canada, brain tumors are the most common cause of childhood cancer death and remain a significant cause of adult mortality. Disease recurrence after surgery and chemotherapy in patients with malignant brain tumors glioblastoma and medulloblastoma proves that conventional therapies miss critical targets necessary for complete cures. The discovery that only a fraction of cancer cells, called cancer stem cells, can divide to reform a tumor, suggests that these are the targets that must be eliminated. However, it is not known if a subpopulation of cells within the cancer stem cell pool withdraw from the cell cycle, making them resistant to standard chemotherapy and radiation. Such silent, or quiescent, cells exist in chronic myelogenous leukemia, but have not been identified in solid tumors like those of the brain. My research will use cell culture, transgenic mouse models, and primary human brain tumor samples to identify, purify, and characterize quiescent brain tumor cancer stem cells. Studying their properties will reveal whether, paradoxically, cells that rarely divide support tumor growth and are the essential therapeutic targets. Molecular and genetic analyses of quiescent cancer stem cells will provide insight into mechanisms of tumor dormancy and resistance to therapy. By understanding the pathways that govern the quiescent state, it will be possible to develop new therapies and treatment strategies that eradicate these essential targets. This study will serve as a model for the characterization and treatment of quiescent cancer stem cells in solid tumors. Its results will have the potential to reduce future brain tumor mortality rates in Canadian children and adults by providing novel approaches for the creation of durable cancer cures.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
217980
Name
Vanner Robert J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Identification and characterization of quiescent brain tumor stem cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Brain Tumor; Cancer; Cancer Heterogeneity; Cancer Stem Cells; Cell Cycle; Quiescence
Abstract
In Canada, brain tumors are the most common cause of childhood cancer death and remain a significant cause of adult mortality. Disease recurrence after surgery and chemotherapy in patients with malignant brain tumors glioblastoma and medulloblastoma proves that conventional therapies miss critical targets necessary for complete cures. The discovery that only a fraction of cancer cells, called cancer stem cells, can divide to reform a tumor, suggests that these are the targets that must be eliminated. However, it is not known if a subpopulation of cells within the cancer stem cell pool withdraw from the cell cycle, making them resistant to standard chemotherapy and radiation. Such silent, or quiescent, cells exist in chronic myelogenous leukemia, but have not been identified in solid tumors like those of the brain. My research will use cell culture, transgenic mouse models, and primary human brain tumor samples to identify, purify, and characterize quiescent brain tumor cancer stem cells. Studying their properties will reveal whether, paradoxically, cells that rarely divide support tumor growth and are the essential therapeutic targets. Molecular and genetic analyses of quiescent cancer stem cells will provide insight into mechanisms of tumor dormancy and resistance to therapy. By understanding the pathways that govern the quiescent state, it will be possible to develop new therapies and treatment strategies that eradicate these essential targets. This study will serve as a model for the characterization and treatment of quiescent cancer stem cells in solid tumors. Its results will have the potential to reduce future brain tumor mortality rates in Canadian children and adults by providing novel approaches for the creation of durable cancer cures.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Vanner, Robert J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~